在肺移植成年囊性纤维化患者的运动处方
Melissa Orlandi1, Maria Stella Pinnarò1, Marco Corsi1
1Sports Medicine Centre, University of Florence, 50100 Florence, Italy.
Journal of functional morphology and kinesiology
|June 26, 2025
概括
接受肺移植的囊性纤维化 (CF) 患者表现出较低的身体组成和心血管功能. 一个个性化的炼计划可以改善这些参数,高峰VO2和身体成分指导处方.
科学领域:
- 心血管呼吸系统生理学
- 移植医学 移植医学
- 运动科学运动科学
背景情况:
- 体育炼干预措施在囊性纤维化 (CF) 管理方面越来越感兴趣.
- 尚未建立任何特定的方法来评估CF患者肺移植后身体组成和心血管性能的改善.
- 这项研究探讨了CF肺移植接受者与其他固体器官移植 (OLT) 接受者相比,在CF肺移植接受者中运动处方的可行性.
研究的目的:
- 为了验证CF肺移植患者的运动处方计划的可行性.
- 为了比较CF肺移植接受者,其他固体器官移植接受者 (OLT) 和健康受试者 (HS) 之间的心肺和身体组成性能.
主要方法:
- 为CF和OLT群体实施了一项中等强度的炼计划.
- 身体组成分析和心肺运动测试 (CPET) 用于评估.
- CF,OLT和HS组进行了比较.
主要成果:
- 与OLT和HS组相比,CF组的BMI,总自由脂肪质量和尾自由脂肪质量明显较低.
- 与OLT和HS组相比,CF患者在CPET期间表现出明显较低的VO2和VO2/HR峰值.
- 在CF组中,观察到自由脂肪质量和功能参数 (峰值VO2,VO2/HR) 之间存在负相关性.
结论:
- 移植后的CF患者可以从个性化的运动处方计划中受益.
- 运动干预可以改善心血管参数和移植CF患者的整体体质.
- 峰值VO2和身体组成指标对于计划CF移植患者的运动处方至关重要.
更多相关视频
07:28Donor Posterior Atrial Flap Rotation for Left Atrial Cuff Reconstruction in Lung Transplantation
Published on: October 11, 2024
434
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
10.8K
相关概念视频
01:24Cystic Fibrosis: Management
229
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
229
01:24Chest Physiotherapy
737
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
737
01:26COPD: Management Using Bronchodilators and Corticosteroids
329
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
329
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:47Lung Capacity
51.5K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
51.5K
01:25Pulmonary Function Tests
438
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
438